MARVIN MCAFEE: Open Payments
NPI 1457602435 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 37 payments from 12 companies in 2025. Trend: 2023 $866 · 2024 $661 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $159 |
| GlaxoSmithKline, LLC. | 10 | $158 |
| ABBVIE INC. | 4 | $62 |
| Amgen Inc. | 4 | $62 |
| PFIZER INC. | 3 | $51 |
| Astellas Pharma US Inc | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Ozempic, VRAYLAR, OTEZLA, Wegovy, Veozah, Auvelity, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
